Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Neoplasms 18 Prostatic Neoplasms 11 Lung Neoplasms 7 Sarcoma 6 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Uterine Cervical Neoplasms 4 Head and Neck Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 3 Lymphoma 3 Hematologic Neoplasms 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Signs and Symptoms 2 Papillomavirus Infections 2 Pain 2 Multiple Myeloma 2 Melanoma 2 Gastrointestinal Neoplasms 2 Financial Stress 2 Endometrial Neoplasms 2 Depression 2 Coitus 2 Chronic Pain 2 Central Nervous System Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2

Interventions

trifluridine tipiracil drug combination 1 trametinib 1 tovorafenib 1 tocilizumab 1 dabrafenib 1 binimetinib 1 anlotinib 1 Surveys and Questionnaires 1 Qsymia 1 Phentermine 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Fluorouracil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Craniopharyngioma × Surveys and Questionnaires × Clear all

NCT06801756 2025-04-02

CRANIOGESTE

Assistance Publique - Hôpitaux de Paris

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡